COMPANY PROFILE

Cardionomic

Explore full profile

Innovative therapies for acute decompensated heart failure, enhancing patient outcomes and reducing readmissions

New Brighton, United StatesFounded 2011Biotech & Life Sciences

Valuation $50–100M Last recorded · 2020

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Cardionomic

Cardionomic Inc. is a medical technology company focused on developing innovative therapies for acute decompensated heart failure (ADHF). Operating in the healthcare sector, Cardionomic serves hospitals and healthcare providers by offering advanced treatment solutions designed to improve patient outcomes and reduce costly readmissions. The company's core product aims to bridge the gap between evidence and practice in ADHF management, enhancing pharmacological tolerance at discharge and extending patient life expectancy. Cardionomic's business model revolves around the development and commercialization of its proprietary therapies, generating revenue through product sales and strategic partnerships with healthcare institutions.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2011
Headquarters: New Brighton, United States
Employees: 4
Open positions: None listed
Dealroom signal: 24.3/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Cardiology and cardiovascular, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
DEBTDebt	Oct 2021	$5M	—	Undisclosed	—
EARLY VC✓Equity / VC	Feb 2020	$16M	$63M	Ascension · Cleveland Clinic · NEA	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Cardionomic website traffic

Latest recorded traffic for Cardionomic is 430 monthly website visits, up 34.4% over the last three months. Cardionomic's team grew 0% over the past year.

Latest monthly visits430 3-month web change+34.4% 1-year team growth0%

Monthly website visitsOct 2017–Sep 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
BIBiotomeDeveloping high-precision antibody diagnostics	City of Nedlands, Australia	Operational	10	$1.1M	$8.4M
AMArtiria MedicalProvides micro-actuated device allowing to treat vascular diseases	Borex, Switzerland	Operational
SPSpectrawaveDiagnosis and treatment of cardiovascular disease through the development of innovative optical diagnostic and therapeutic devices	Waltham, United States	Acquired
BIBiVACORDesigns and manufactures centrifugal heart pumps	Houston, United States	Operational
CRCroivalveTreating Heart Valve Disease	Dublin, Ireland	Operational
RHRheoDxA precise and portable in-vitro device that immediately diagnose hematological diseases with a single blood drop	Barcelona, Spain	Operational
MTMicell TechnologiesBiomedical device company developing interventional cardiology systems for vascular drug delivery	Durham, United States	Operational
BMBioTrace MedicalBioTrace Medical, Inc is dedicated to reinventing temporary pacing to improve patient outcomes and reduce hospital costs	San Carlos, United States	Operational